Latest News
Modeling T Cell Dysfunction: New Frontiers in Immunometabolism
While cancer immunotherapies—particularly immune checkpoint blockades (ICBs)—have transformed clinical oncology, primary and acquired resistance remain major hurdles in solid tumors. Mounting evidence reveals that this non-responsiveness is deeply tied to the...
Latest News
Next-Gen 3D Models: A Webinar on Elevating Brain Organoid Fidelity
Human brain organoids have fundamentally shifted the paradigm of neurological research. By transforming human pluripotent stem cells (hPSCs) into self-organizing, three-dimensional tissues, these models provide an unprecedented window into the distinct spatial...
Weekly News Roundup | 20 July 2026
Life science news 20 July 2026: the FDA approves the first oral PCSK9 inhibitor for high cholesterol, Eli Lilly makes the largest psychedelics deal in Big Pharma history, and a first-in-class breast cancer therapy wins regulatory clearance in a landmark week for...
The NewCo Model: How Big Pharma Spins Out Pipeline Assets
The NewCo model biopharma strategy has rapidly become one of the most consequential dealmaking trends in the life sciences industry. Rather than shelving deprioritised pipeline assets or selling them outright through traditional licensing agreements, major...
Diranersen: First Tau Drug to Show Cognitive Benefit in Alzheimer’s
The first Phase 2 clinical evidence that a tau Alzheimer's drug can simultaneously reduce brain tangles and slow cognitive decline was presented at the Alzheimer's Association International Conference (AAIC) 2026 in London on 14 July. Biogen's diranersen, an antisense...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Python Blood Molecule Opens Door to New Obesity Treatments
Scientists studying the extraordinary metabolism of Burmese pythons have identified a python blood molecule that dramatically suppresses appetite in obese mice, raising the prospect of a new class of weight loss therapies that could avoid some of the side effects...
Weekly News Roundup | 30 March 2026
Life science news 30 March 2026: Three blockbuster deals, two FDA accelerated approvals and intensifying GLP-1 competition headline a busy week for pharma and biotech. Merck agreed on 25 March to acquire Terns Pharmaceuticals for $6.7 billion, gaining access to...
International Menopause Society Unveils Global Care Framework
International Menopause Society sets new global standards for menopause care with evidence-led framework For the first time in a decade, the International Menopause Society (IMS) has released a complete redevelopment of its global menopause recommendations. Grounded...
Clinical Trials Roundup | 27 March 2026
An RNA therapy that preserves muscle while cutting visceral fat, a first in class oral non incretin obesity pill, late stage lung cancer portfolio data, NK cell immunotherapy in Alzheimer’s disease, and the first human trial of a cellular rejuvenation medicine...
New Report Highlights Why CGTs Still Struggle at Market Access
Cell and gene therapies are approved — so why aren’t they reaching patients? New industry report warns access systems — not science — are now the primary bottleneck A new report from Phacilitate argues that the biggest threat to cell and gene therapy (CGT) expansion...
The Radical Longevity Science Frontier
For decades, longevity has been a frontier of scientific exploration, pushing the boundaries of what we believe is possible for human health and lifespan. While incremental progress has been made in understanding the biology of aging, we are now on the cusp of a new...
Key Thoughts from the on! PLUS TPL Review
The evolving PMTA landscape for nicotine pouches The recent FDA authorisation of on! PLUS nicotine pouches is a significant moment in helping meet tobacco harm reduction (THR) goals. They are the first products to pass a new, faster FDA programme, signifying a...
How to Move Faster Without Losing Scientific Rigor or Compliance
Life science organizations are under pressure to do two things at once: communicate complex science with precision and keep pace with a digital market that moves in days, not quarters. This tension defines one of the most consequential challenges in modern life...
Agentic AI is Having a Moment: The Foundations go Back 40 Years
The application of agentic AI in life sciences reached a tipping point in 2025. Frameworks where specialized agents collaborate on tasks, sharing work, dividing problems, communicating with each other, went from an emerging topic to the predominant conversation. For...
From Flower to Pharmacy: The Science Behind Manuka Honey
Not all honey is created equal. That statement, once dismissed as marketing language, is now well-supported by peer-reviewed chemistry. Manuka honey is produced by bees foraging on Leptospermum scoparium, a flowering shrub native to New Zealand and south-eastern...
Weekly News Roundup | 23 March 2026
Your essential life science news 23 March 2026 digest: the past week’s biggest stories in pharma, biotech and healthcare. The FDA approved Johnson and Johnson's once-daily psoriasis pill ICOTYDE (icotrokinra) on 18 March, making it the world's first oral peptide to...
Clinical Trials Roundup
This week brought a remarkable series of clinical trial readouts spanning oncology, metabolic disease, neurology, and dermatology. Several pivotal datasets were released from late-stage and early-stage programmes, offering fresh hope for patients with conditions...
Python Blood Molecule Opens Door to New Obesity Treatments
Scientists studying the extraordinary metabolism of Burmese pythons have identified a python blood molecule that dramatically suppresses appetite in obese mice, raising the prospect of a new class of weight loss therapies that could avoid some of the side effects...
Weekly News Roundup | 30 March 2026
Life science news 30 March 2026: Three blockbuster deals, two FDA accelerated approvals and intensifying GLP-1 competition headline a busy week for pharma and biotech. Merck agreed on 25 March to acquire Terns Pharmaceuticals for $6.7 billion, gaining access to...
International Menopause Society Unveils Global Care Framework
International Menopause Society sets new global standards for menopause care with evidence-led framework For the first time in a decade, the International Menopause Society (IMS) has released a complete redevelopment of its global menopause recommendations. Grounded...
Clinical Trials Roundup | 27 March 2026
An RNA therapy that preserves muscle while cutting visceral fat, a first in class oral non incretin obesity pill, late stage lung cancer portfolio data, NK cell immunotherapy in Alzheimer’s disease, and the first human trial of a cellular rejuvenation medicine...
New Report Highlights Why CGTs Still Struggle at Market Access
Cell and gene therapies are approved — so why aren’t they reaching patients? New industry report warns access systems — not science — are now the primary bottleneck A new report from Phacilitate argues that the biggest threat to cell and gene therapy (CGT) expansion...
The Radical Longevity Science Frontier
For decades, longevity has been a frontier of scientific exploration, pushing the boundaries of what we believe is possible for human health and lifespan. While incremental progress has been made in understanding the biology of aging, we are now on the cusp of a new...
Key Thoughts from the on! PLUS TPL Review
The evolving PMTA landscape for nicotine pouches The recent FDA authorisation of on! PLUS nicotine pouches is a significant moment in helping meet tobacco harm reduction (THR) goals. They are the first products to pass a new, faster FDA programme, signifying a...
How to Move Faster Without Losing Scientific Rigor or Compliance
Life science organizations are under pressure to do two things at once: communicate complex science with precision and keep pace with a digital market that moves in days, not quarters. This tension defines one of the most consequential challenges in modern life...
Agentic AI is Having a Moment: The Foundations go Back 40 Years
The application of agentic AI in life sciences reached a tipping point in 2025. Frameworks where specialized agents collaborate on tasks, sharing work, dividing problems, communicating with each other, went from an emerging topic to the predominant conversation. For...
From Flower to Pharmacy: The Science Behind Manuka Honey
Not all honey is created equal. That statement, once dismissed as marketing language, is now well-supported by peer-reviewed chemistry. Manuka honey is produced by bees foraging on Leptospermum scoparium, a flowering shrub native to New Zealand and south-eastern...
Weekly News Roundup | 23 March 2026
Your essential life science news 23 March 2026 digest: the past week’s biggest stories in pharma, biotech and healthcare. The FDA approved Johnson and Johnson's once-daily psoriasis pill ICOTYDE (icotrokinra) on 18 March, making it the world's first oral peptide to...
Clinical Trials Roundup
This week brought a remarkable series of clinical trial readouts spanning oncology, metabolic disease, neurology, and dermatology. Several pivotal datasets were released from late-stage and early-stage programmes, offering fresh hope for patients with conditions...
Featured Articles
Further News
Power Outages as a Clinical Risk Multiplier in Healthcare
Electricity as a Hidden Dependency in Healthcare Reliable electricity is a foundational requirement for modern healthcare systems. From acute hospital care to long-term residential facilities and home-based treatment, uninterrupted power underpins virtually every...
I’m a Menopause Doctor – Here’s the Real Problem with Fezolinetant
With news of a HRT alternative for women struggling with hot flushes now available on the NHS, Dr Louise Newson explains why when it comes to Fezolinetant, women need to proceed with caution. UK medicines regulator NICE reported that they're in the final stages of...
The Physician Gap That’s Slowing Life Sciences
We work with hospitals, clinics, and health systems across the country every day. Over the past few years, one thing has become very clear: filling a specialist role is harder than it used to be, it takes longer, and the consequences of getting it wrong reach further...
Bridging the Gap Between Microbiome Research and Patient Care
Advances in microbiome science are occurring faster than our ability to apply these insights within complex human systems. While research has dramatically expanded what can be observed within the gut, translating these discoveries into meaningful improvements in...
Protecting R&D and Clinical Trial Data in the Age of AI
Drug development is one of the most expensive and time-intensive innovation processes in the world. Estimates from the Tufts Center for the Study of Drug Development suggest that bringing a new drug to market can cost over $2.6 billion and take more than a decade of...
Medical Writers Become Strategic Partners
In regulated drug development, documentation shapes how a program is understood long before regulators ever see it. Protocols, investigator brochures, integrated summaries, and submission-ready modules establish the scientific and strategic narrative of a development...
HIV Treatment Revolution: Infected Cells Now Trigger Their Own Elimination
Imagine a virus so cunning it hides in your body's own cells, evading detection for decades while you take daily pills just to keep it at bay. That's the reality for nearly 40 million people living with HIV worldwide. But what if we could flip the script—turning those...
Microplastics From Food Packaging Linked to Liver Damage, New Study Finds
New research has found that microplastics from food packaging could cause damage to the normal function and health of the liver. Microplastics - small fragments less than 5mm in size - are already known to be widespread in the food and drink that we consume. It is...
Weekly News Roundup | 16 March 2026
Your essential life science news digest: the past week's biggest stories in pharma, biotech and healthcare. 👇 This week's life science news was defined by regulatory uncertainty and clinical momentum. A landmark FDA leadership departure sent rare disease stocks...
Imperial, Oxford & GSK launch £11M Digital Twin Organ Centre
Imperial College London, University of Oxford and GSK Launch £11 Million Centre to Build Digital Twins of Human Organs A new research centre backed by £11 million in funding has been established by Imperial College London, the University of Oxford and GSK to develop...
Reflections and Healing at the End of Life
Words To Begin At age 81, the author has lived a "life of letters" (perhaps three million words) addressing a wide variety of subjects during multiple careers: Systems Engineering (PhD at UCLA in 1976), Military Science (21 years on active duty, in high-tech...
Why Fertility Diagnostics Must Move to Continuous Remote Monitoring
In cardiology and diabetes, we no longer rely on single, in-clinic readings to diagnose complex conditions; instead, remote monitors are used to capture data over a period of time. We’ve seen that the standard of care across medicine is shifting from episodic...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.